HSGX
Histogenics Corp
Halal Rating :
Last Price
$0.71
Last updated:
Market Cap
-
7D Change
-5.48%
1 Year Change
33.0%
Company Overview
Exchange
Next Earnings Date
Histogenics Corporation was a clinical-stage biotechnology company that focused on developing tissue repair treatments. In 2019, the company completed a reverse merger with Ocugen, Inc. The combined company now operates as Ocugen (NASDAQ: OCGN) and focuses on developing gene therapies and vaccines.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.14m | $14.39m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.14m | $16.59m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.01m | $13.23m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Histogenics Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.